Siga Technologies Inc SIGA
Institutional shares held
35.6 Million
873K
calls
466K
puts
Total value of holdings
$220M
$5.38M
calls
$2.87M
puts
Market Cap
$437M
73,024,096
Shares Out.
Institutional ownership
48.82%
# of Institutions
185
We take great care to ensure that the data presented and summarized in this overview for SIGA TECHNOLOGIES INC is accurate and up-to-date, based on a comprehensive analysis of 13F filing forms for institutional ownership and form 4 filings for insider transactions. Please note that this data may differ from other sources and should not be relied upon as the sole basis for investment decisions.
Top Institutions Holding SIGA
View all-
Black Rock Inc. New York, NY3.91MShares$23.4 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.57MShares$15.3 Million0.0% of portfolio
-
First Wilshire Securities Management Inc Pasadena, CA2.44MShares$14.6 Million4.63% of portfolio
-
Altra Vue Capital, LLC Bellevue, WA2.31MShares$13.8 Million1.61% of portfolio
-
Hotchkis & Wiley Capital Management LLC Los Angeles, CA2.05MShares$12.2 Million0.05% of portfolio
-
Dimensional Fund Advisors LP Austin, TX1.91MShares$11.4 Million0.0% of portfolio
-
American Century Companies Inc Kansas City, MO1.16MShares$6.92 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA1.11MShares$6.65 Million0.0% of portfolio
-
State Street Corp Boston, MA1.1MShares$6.56 Million0.0% of portfolio
-
Ken Griffin Citadel Advisors LLC | Chicago, Il1.07MShares$6.39 Million0.0% of portfolio
Latest Institutional Activity in SIGA
Top Purchases
Top Sells
About SIGA
SIGA Technologies, Inc., a commercial-stage pharmaceutical company, focuses on the health security and infectious disease markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. SIGA Technologies, Inc. has a strategic partnership with Cipla Therapeutics to deliver sustained innovation and access to antibacterial drugs primarily against biothreats. The company was incorporated in 1995 and is headquartered in New York, New York.
Insider Transactions at SIGA
Insider Transaction List
View all| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jan 27
2025
|
Diem Nguyen Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,644
-25.9%
|
$141,864
$6.34 P/Share
|
|
Jan 27
2025
|
Diem Nguyen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
55,902
+37.98%
|
-
|
|
Oct 25
2024
|
Diem Nguyen Chief Executive Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
23,893
-40.3%
|
$143,358
$6.77 P/Share
|
|
Oct 25
2024
|
Diem Nguyen Chief Executive Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
59,288
+50.0%
|
-
|
|
Jul 01
2024
|
Daniel J Luckshire Executive VP & CFO |
SELL
Payment of exercise price or tax liability
|
Direct |
12,347
-4.48%
|
$86,429
$7.55 P/Share
|
|
Jul 01
2024
|
Daniel J Luckshire Executive VP & CFO |
BUY
Exercise of conversion of derivative security
|
Direct |
24,194
+8.07%
|
-
|
|
Jul 01
2024
|
Dennis E Hruby EVP & Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
10,467
-5.82%
|
$73,269
$7.55 P/Share
|
|
Jul 01
2024
|
Dennis E Hruby EVP & Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
32,258
+15.22%
|
-
|
|
Jun 11
2024
|
Jay Varma EVP & Chief Medical Officer |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-30.0%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Jay Varma EVP & Chief Medical Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+50.0%
|
-
|
|
Jun 11
2024
|
Julian Nemirovsky |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Julian Nemirovsky |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Holly L. Phillips |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Holly L. Phillips |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Joseph W Marshall Iii |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-3.31%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Joseph W Marshall Iii |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+9.95%
|
-
|
|
Jun 11
2024
|
Gary J. Nabel |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-14.56%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Gary J. Nabel |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+32.67%
|
-
|
|
Jun 11
2024
|
Harold Eugene Ford Jr. |
SELL
Sale (or disposition) back to the issuer
|
Direct |
7,414
-30.0%
|
$51,898
$7.86 P/Share
|
|
Jun 11
2024
|
Harold Eugene Ford Jr. |
BUY
Exercise of conversion of derivative security
|
Direct |
24,712
+50.0%
|
-
|
Last 12 Months Summary
Buy / Acquisition
419K
Shares
From
12
Insiders
| Exercise of conversion of derivative security | 369K shares |
|---|---|
| Grant, award, or other acquisition | 49.9K shares |
Sell / Disposition
149K
Shares
From
12
Insiders
| Sale (or disposition) back to the issuer | 59.3K shares |
|---|---|
| Payment of exercise price or tax liability | 89.4K shares |